BirchBioMed Inc., a leading clinical stage biopharmaceutical company, expert in the development of products for scarring and other fibrosis-related disorders and autoimmune therapeutics, today ...

Pulmonary fibrosis—also known in technical terms as idiopathic pulmonary fibrosis (IPF)—is a rare but life-threatening ...

Her resilience and openness helped spark wider conversations about this often misunderstood condition. To better understand IPF, we reached out to Dr Sunil Kumar K, Lead Consultant – Interventional ...

The Pulmonary Fibrosis Foundation (PFF) today announced a new five-year strategic plan, The PFF is ME, a community-driven roadmap shaped by input from more than 350 people affected by pulmonary ...

United Therapeutics' stock surged after IPF trial results and what future pivotal trials could mean for investors. See here ...

Researchers at the University of Arizona have uncovered a previously unknown population of circulating immune cells that play ...

Early diagnosis and treatment in IPF and PPF are vital, as fibrosis is irreversible and current therapies only slow progression. Current IPF treatments, pirfenidone and nintedanib, have significant ...

Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...

Researchers discover circulating immune cells that drive fibrosis, revealing a new therapeutic target to prevent scar tissue ...

Rambling Rose' star Diane Ladd's cause of death has been revealed, weeks after her daughter Laura Dern announced her death ...

-Similar patents have also been granted in key markets around the world including the United States, China, and Japan -Brilaroxazine has a novel mechanism of action for treating the underlying ...